Avinger (AVGR) Trading Up 2.9%

Shares of Avinger Inc (NASDAQ:AVGR) were up 2.9% during trading on Thursday . The company traded as high as $0.37 and last traded at $0.35. Approximately 220,769 shares changed hands during trading, a decline of 84% from the average daily volume of 1,404,119 shares. The stock had previously closed at $0.34.

Separately, Zacks Investment Research raised Avinger from a “hold” rating to a “buy” rating and set a $0.25 price target for the company in a research report on Tuesday, November 20th.

The stock has a market capitalization of $7.86 million, a P/E ratio of 0.00 and a beta of 1.99.

Avinger (NASDAQ:AVGR) last issued its quarterly earnings results on Tuesday, November 13th. The medical device company reported ($0.56) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.51) by ($0.05). The business had revenue of $2.02 million during the quarter. As a group, analysts predict that Avinger Inc will post -7.19 EPS for the current year.

TRADEMARK VIOLATION WARNING: This news story was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/12/06/avinger-avgr-trading-up-2-9.html.

Avinger Company Profile (NASDAQ:AVGR)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Featured Story: The Role of a Fiduciary and Individual Investors

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply